GGrantIndex
Sort

39,280 grants matching leukemia

Pathophysiology and Treatment of Fanconi Anemia

$1,985,543
Markus Grompe · Oregon Health & Science University · P01 · FY2018 · HL

Mixed Hematopoietic Chimerism after Stem Cell Allografts

$1,985,492
Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2007 · CA

Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy

$1,985,262
Daniel Fowler · Clinical Sciences · Z01 · FY2007 · CA

Genes and signals controlling mammalian hematopoiesis.

$1,984,290
Paul E Love · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2017 · HD

Molecular Genetics of Fanconi Anemia

$1,983,074
Robb E Moses · Oregon Health & Science University · P01 · FY2006 · HL

Off-the-Shelf Immune Effector Cells for Hematological Malignancies

$1,982,660
John E Wagner · University Of Minnesota · P01 · FY2024 · CA

Retrovirus Models of Lymphocyte Transformation/Disease

$1,980,571
Michael D Lairmore · Ohio State University · P01 · FY2007 · CA

Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease

$1,980,543
Amy Klion · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

Chromatin Insulator Function and Nuclear Organization

$1,980,490
Elissa Lei · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK

PAAR-Pharmacogenomics of Anticancer Agents Research Group

$1,979,869
Mark J Ratain · University Of Chicago · U01 · FY2012 · GM

Pathophysiology and Treatment of Fanconi Anemia

$1,979,462
Markus Grompe · Oregon Health & Science University · P01 · FY2019 · HL

Molecular Genetics of Fanconi Anemia

$1,979,370
Robb E Moses · Oregon Health & Science University · P01 · FY2007 · HL

Repository Services for epidemiology studies

$1,978,965
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2011 · CA

Quantitative and functional characterization of therapeutic resistance in cancer

$1,977,498
Scott R Manalis · Massachusetts Institute Of Technology · U54 · FY2017 · CA

Clinical and translational studies of RUNX1 and FPDMM

$1,976,750
Paul Liu · National Human Genome Research Institute · ZIA · FY2023 · HG

Flow cytometric analysis of benign and malignant tumors

$1,976,620
Hao-Wei Wang · Division Of Clinical Sciences - Nci · ZIC · FY2022 · CA

Quantitative and functional characterization of therapeutic resistance in cancer

$1,976,036
Scott R Manalis · Massachusetts Institute Of Technology · U54 · FY2021 · CA

Molecular Genetics of Fanconi Anemia

$1,975,695
Oregon Health And Science University · P01 · FY2005 · HL

Understanding and Targeting Wild-Type SS18 Function and Stability in Synovial Sarcoma

$1,975,000
Ali Shilatifard · Dana-Farber Cancer Inst · U54 · FY2018 · CA

Molecular Pathways to Thymic Lymphoma and Leukemia

$1,974,630
A Thomas Look · Dana-Farber Cancer Inst · P01 · FY2008 · CA

Pathophysiology and Treatment of Fanconi Anemia

$1,973,219
Markus Grompe · Oregon Health & Science University · P01 · FY2020 · HL

Immunogenetics of Graft-Versus-Host Disease

$1,973,012
Effie W Petersdorf · Fred Hutchinson Cancer Research Center · P01 · FY2013 · CA

Studies of Occupational Cancer (Pesticides)

$1,972,780
Michael Alavanja · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA

Cancer Risk and Environmental Exposures

$1,972,751
Mary H Ward · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA

Retrovirus Models of Cancer

$1,971,061
Lee Ratner · Washington University · P01 · FY2025 · CA